Edwards Lifesciences Corporation
EW
Edwards Lifesciences Corporation is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence, and meaningful partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most.
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$6.67B
▲ +11.5% YoY
Net Income (TTM)
$1.02B
▼ -74.3% YoY
Op. Margin
21.59%
▼ -4.5pp YoY
ROIC
8.86%
▼ -4.0pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$1.42B
▲ +360.5% YoY
Op. Cash Flow (TTM)
$1.72B
▲ +194.2% YoY
Net Debt
-$3.94B
Net Cash Position
Cash & Equiv.
$4.64B
5Y CAGR: +6.7%
5Y CAGR: +15.6%
Continue Research
Peers
Orthopedic, Prosthetic & Surgical Appliances & Supplies · Pick stocks to compare with EW
Held by ETFs
EW is in 288 US ETFs. The largest of them, with EW's weight in each:
Edwards Lifesciences (EW) in four numbers
Questions about Edwards Lifesciences
Is Edwards Lifesciences (EW) overvalued?
At $105.43, Edwards Lifesciences' price is 116% above the $48.90 a share fair value that Intrinsiqq's calculator gets from its earnings. It trades at 59.56 times earnings and 42.57 times free cash flow. The growth behind that figure is yours to set on the Intrinsic Value tab. See how to tell if a stock is overvalued.
What is Edwards Lifesciences' fair value?
Intrinsiqq's calculator puts Edwards Lifesciences' fair value at $48.90 a share. It grows earnings per share 8.2% a year for 5 years, applies an exit P/E of 30, and works back at a 10% yearly return. A 25% margin of safety gives a buy-below price of $36.67. Every input can be changed on the Intrinsic Value tab.
Is Edwards Lifesciences a high-quality business?
Edwards Lifesciences scores 60 out of 100 on Intrinsiqq's quality score, which makes it a solid business on these measures. The score blends 8 checks computed from SEC filings. Its best check is revenue growth at 10.6%, and its weakest is margin trend at -12.0pp. The Quality tab shows every check against its target.
Does Edwards Lifesciences (EW) pay a dividend?
No. Edwards Lifesciences (EW) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Over the last twelve months it returned cash through share buybacks instead, equal to a 1.2% buyback yield. The Dividends tab shows its cash returns.
Source: 10-Q filed 31 Oct 2026 (period ending 30 Sept 2026), SEC. Price: last close 17 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.
Spot a number that looks wrong? Check it in EW's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing EW
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.